Clinical Trial Update: Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a short-course regimen with bedaquiline, moxifloxacin, and pyrazinamide for early bactericidal activity in drug-susceptible pulmonary t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-susceptible Pulmonary Tuberculosis
• Pulmonary Tuberculosis

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• Pyrazinamide (pyrazinamide)
• bedaquiline (bedaquiline)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis | Phase 2 | Status: NOT_YET_RECRUITING